Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 30 | 2023 | 3637 | 1.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 31 | 2022 | 11858 | 0.850 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2021 | 685 | 0.850 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 1 | 2021 | 37 | 0.760 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2022 | 1559 | 0.740 |
Why?
|
Pyrimidines | 5 | 2020 | 3049 | 0.460 |
Why?
|
Thiazoles | 2 | 2011 | 1528 | 0.430 |
Why?
|
Cytarabine | 12 | 2019 | 696 | 0.410 |
Why?
|
fms-Like Tyrosine Kinase 3 | 5 | 2017 | 496 | 0.400 |
Why?
|
Leukemia, Myeloid | 7 | 2019 | 695 | 0.400 |
Why?
|
Remission Induction | 16 | 2022 | 2413 | 0.380 |
Why?
|
Glutarates | 3 | 2018 | 243 | 0.330 |
Why?
|
Head and Neck Neoplasms | 9 | 2005 | 2924 | 0.290 |
Why?
|
Aminoacridines | 5 | 1984 | 9 | 0.290 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2002 | 243 | 0.280 |
Why?
|
Carcinoma, Squamous Cell | 9 | 2005 | 4044 | 0.270 |
Why?
|
Azepines | 2 | 2019 | 327 | 0.260 |
Why?
|
Maximum Tolerated Dose | 8 | 2019 | 895 | 0.250 |
Why?
|
Translocation, Genetic | 4 | 2014 | 1393 | 0.240 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2019 | 1643 | 0.240 |
Why?
|
Asparaginase | 2 | 2017 | 240 | 0.230 |
Why?
|
Jehovah's Witnesses | 1 | 2004 | 13 | 0.230 |
Why?
|
Mitoxantrone | 6 | 2019 | 148 | 0.230 |
Why?
|
Vincristine | 5 | 2022 | 1037 | 0.220 |
Why?
|
Freedom | 1 | 2004 | 69 | 0.220 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2023 | 954 | 0.220 |
Why?
|
Myelodysplastic Syndromes | 3 | 2019 | 1404 | 0.210 |
Why?
|
Proto-Oncogenes | 1 | 2004 | 320 | 0.210 |
Why?
|
Antineoplastic Agents | 12 | 2019 | 13631 | 0.200 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2004 | 412 | 0.200 |
Why?
|
Nose Neoplasms | 2 | 2002 | 249 | 0.200 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2004 | 417 | 0.200 |
Why?
|
Leukemia, Eosinophilic, Acute | 1 | 2021 | 5 | 0.200 |
Why?
|
Treatment Refusal | 2 | 2004 | 433 | 0.190 |
Why?
|
Steel | 1 | 2021 | 27 | 0.190 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2022 | 1609 | 0.180 |
Why?
|
Oral Ulcer | 1 | 2021 | 95 | 0.180 |
Why?
|
Idarubicin | 4 | 2019 | 59 | 0.180 |
Why?
|
Esthesioneuroblastoma, Olfactory | 2 | 1999 | 57 | 0.170 |
Why?
|
Boron Compounds | 1 | 2022 | 195 | 0.170 |
Why?
|
Blood Transfusion | 2 | 2004 | 1307 | 0.170 |
Why?
|
Blast Crisis | 1 | 2020 | 102 | 0.170 |
Why?
|
Leukemia | 3 | 2004 | 1522 | 0.170 |
Why?
|
Philadelphia Chromosome | 1 | 2020 | 119 | 0.160 |
Why?
|
Aged | 53 | 2022 | 171163 | 0.160 |
Why?
|
Fluorouracil | 5 | 2000 | 1648 | 0.160 |
Why?
|
Cisplatin | 7 | 2002 | 1654 | 0.160 |
Why?
|
Hematologic Neoplasms | 1 | 2011 | 1926 | 0.160 |
Why?
|
Mutation | 10 | 2019 | 30192 | 0.160 |
Why?
|
Uridine | 1 | 2019 | 135 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2023 | 474 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2019 | 5333 | 0.150 |
Why?
|
Etoposide | 5 | 2019 | 636 | 0.150 |
Why?
|
Glycine | 1 | 2022 | 671 | 0.150 |
Why?
|
Alveolar Ridge Augmentation | 1 | 2020 | 206 | 0.150 |
Why?
|
Alveolar Bone Loss | 1 | 2020 | 394 | 0.140 |
Why?
|
Neoplasm Invasiveness | 1 | 2005 | 3599 | 0.140 |
Why?
|
Antigens, CD19 | 1 | 2020 | 442 | 0.140 |
Why?
|
Middle Aged | 60 | 2020 | 223016 | 0.140 |
Why?
|
Humans | 89 | 2023 | 765926 | 0.130 |
Why?
|
Male | 62 | 2022 | 363815 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2002 | 655 | 0.120 |
Why?
|
Recurrence | 7 | 2023 | 8492 | 0.120 |
Why?
|
SEER Program | 3 | 2017 | 1443 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2013 | 9373 | 0.120 |
Why?
|
Bone Marrow | 5 | 2021 | 2916 | 0.120 |
Why?
|
Antifungal Agents | 1 | 2020 | 769 | 0.120 |
Why?
|
Bleomycin | 3 | 1992 | 491 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 3 | 2017 | 5691 | 0.120 |
Why?
|
Glutamine | 1 | 2017 | 574 | 0.120 |
Why?
|
Anilides | 1 | 2017 | 413 | 0.120 |
Why?
|
Core Binding Factors | 1 | 2014 | 29 | 0.110 |
Why?
|
Female | 63 | 2021 | 396141 | 0.110 |
Why?
|
Sarcoma, Myeloid | 1 | 2014 | 52 | 0.110 |
Why?
|
Myeloproliferative Disorders | 2 | 2011 | 615 | 0.110 |
Why?
|
Aziridines | 3 | 1998 | 23 | 0.110 |
Why?
|
Drug Administration Schedule | 7 | 2019 | 4851 | 0.110 |
Why?
|
Adult | 45 | 2020 | 223088 | 0.100 |
Why?
|
Physician-Patient Relations | 2 | 2018 | 3270 | 0.100 |
Why?
|
Survival Analysis | 9 | 2017 | 10086 | 0.100 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 1997 | 340 | 0.100 |
Why?
|
Benzoquinones | 3 | 1998 | 197 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2020 | 994 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 36547 | 0.100 |
Why?
|
Treatment Outcome | 15 | 2022 | 65194 | 0.100 |
Why?
|
Dental Implants | 1 | 2020 | 790 | 0.100 |
Why?
|
Immunoconjugates | 1 | 2019 | 976 | 0.100 |
Why?
|
Combined Modality Therapy | 7 | 2016 | 8522 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5752 | 0.100 |
Why?
|
Survival Rate | 8 | 2018 | 12822 | 0.090 |
Why?
|
Boronic Acids | 3 | 2013 | 915 | 0.090 |
Why?
|
Prognosis | 12 | 2019 | 29890 | 0.090 |
Why?
|
Leukocytosis | 1 | 2012 | 249 | 0.090 |
Why?
|
Affect | 1 | 2019 | 1494 | 0.090 |
Why?
|
Aged, 80 and over | 18 | 2020 | 59496 | 0.090 |
Why?
|
Chromosomes, Human, Pair 21 | 2 | 2014 | 228 | 0.090 |
Why?
|
Amsacrine | 6 | 1986 | 19 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1504 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2005 | 9600 | 0.090 |
Why?
|
Disease-Free Survival | 8 | 2019 | 6838 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1140 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2022 | 2510 | 0.080 |
Why?
|
Salivary Gland Neoplasms | 2 | 2004 | 305 | 0.080 |
Why?
|
Pyrazines | 3 | 2013 | 1204 | 0.080 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2021 | 2805 | 0.080 |
Why?
|
Cell Death | 1 | 2015 | 1676 | 0.080 |
Why?
|
Methotrexate | 2 | 2014 | 1719 | 0.080 |
Why?
|
Salvage Therapy | 5 | 2017 | 1272 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2017 | 873 | 0.080 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2010 | 249 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2021 | 3560 | 0.080 |
Why?
|
Interferon-alpha | 1 | 1993 | 909 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1365 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 2017 | 3716 | 0.070 |
Why?
|
Hospitalization | 2 | 2019 | 10810 | 0.070 |
Why?
|
Transcription Factors | 2 | 2005 | 12129 | 0.070 |
Why?
|
Radiography, Abdominal | 1 | 2011 | 543 | 0.070 |
Why?
|
Quinazolines | 1 | 2013 | 1366 | 0.070 |
Why?
|
Budd-Chiari Syndrome | 1 | 2006 | 24 | 0.070 |
Why?
|
Drug Evaluation | 6 | 1986 | 642 | 0.070 |
Why?
|
Nausea | 3 | 1999 | 678 | 0.070 |
Why?
|
Interleukin-2 | 1 | 1993 | 1894 | 0.060 |
Why?
|
Central Nervous System Neoplasms | 1 | 2014 | 918 | 0.060 |
Why?
|
Amifostine | 1 | 2005 | 39 | 0.060 |
Why?
|
Vascular Neoplasms | 1 | 2007 | 167 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2019 | 3799 | 0.060 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 1163 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2017 | 1945 | 0.060 |
Why?
|
Pyridines | 1 | 2017 | 2885 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 3 | 2013 | 645 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2019 | 5339 | 0.060 |
Why?
|
Radiotherapy Dosage | 2 | 2005 | 2863 | 0.060 |
Why?
|
Acute Disease | 7 | 2019 | 7236 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1086 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2520 | 0.060 |
Why?
|
Purine Nucleosides | 1 | 2003 | 30 | 0.060 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2004 | 89 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2008 | 2270 | 0.060 |
Why?
|
Minors | 1 | 2004 | 59 | 0.050 |
Why?
|
Chromosomes, Human, X | 1 | 2005 | 319 | 0.050 |
Why?
|
Terminal Care | 1 | 2015 | 1769 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1600 | 0.050 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39228 | 0.050 |
Why?
|
Leukopenia | 3 | 1992 | 213 | 0.050 |
Why?
|
Young Adult | 9 | 2020 | 59857 | 0.050 |
Why?
|
Ultrafiltration | 1 | 1982 | 46 | 0.050 |
Why?
|
Centrifugation | 1 | 1982 | 121 | 0.050 |
Why?
|
Neoplasm Staging | 4 | 2019 | 11196 | 0.050 |
Why?
|
Identity Crisis | 1 | 2002 | 12 | 0.050 |
Why?
|
Paclitaxel | 3 | 2005 | 1726 | 0.050 |
Why?
|
Faith Healing | 1 | 2002 | 25 | 0.050 |
Why?
|
Leukapheresis | 1 | 1982 | 150 | 0.050 |
Why?
|
Germany | 1 | 2004 | 882 | 0.050 |
Why?
|
Radiotherapy, High-Energy | 1 | 2002 | 226 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2014 | 2068 | 0.050 |
Why?
|
Tandem Repeat Sequences | 2 | 2012 | 184 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3230 | 0.050 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2004 | 309 | 0.050 |
Why?
|
Isoflurophate | 1 | 1980 | 27 | 0.050 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 165 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 943 | 0.040 |
Why?
|
Lung Diseases, Interstitial | 1 | 2009 | 940 | 0.040 |
Why?
|
Particle Accelerators | 1 | 2021 | 172 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2005 | 1777 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2474 | 0.040 |
Why?
|
Taxoids | 2 | 2000 | 665 | 0.040 |
Why?
|
Blood | 1 | 1982 | 597 | 0.040 |
Why?
|
Acanthocytes | 1 | 1979 | 3 | 0.040 |
Why?
|
Diffusion | 1 | 2021 | 808 | 0.040 |
Why?
|
Adolescent | 10 | 2017 | 88811 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3796 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4111 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2004 | 698 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2005 | 1775 | 0.040 |
Why?
|
Rotation | 1 | 2021 | 513 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 745 | 0.040 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2002 | 325 | 0.040 |
Why?
|
Erythrocytes, Abnormal | 1 | 1979 | 122 | 0.040 |
Why?
|
Dermatitis, Exfoliative | 1 | 1978 | 28 | 0.040 |
Why?
|
Computer-Aided Design | 1 | 2020 | 290 | 0.040 |
Why?
|
Pancytopenia | 1 | 1979 | 102 | 0.040 |
Why?
|
Thrombopoietin | 1 | 2000 | 225 | 0.040 |
Why?
|
Imidazoles | 1 | 2004 | 1164 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2004 | 1136 | 0.040 |
Why?
|
Choroid Neoplasms | 1 | 1999 | 175 | 0.040 |
Why?
|
Cytogenetic Analysis | 2 | 2011 | 270 | 0.040 |
Why?
|
Administration, Oral | 3 | 2019 | 4016 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1433 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18074 | 0.030 |
Why?
|
Stomatitis | 1 | 1999 | 270 | 0.030 |
Why?
|
Eosinophilia | 1 | 2021 | 553 | 0.030 |
Why?
|
Anthracyclines | 1 | 2019 | 285 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1980 | 747 | 0.030 |
Why?
|
Nasal Cavity | 1 | 1999 | 309 | 0.030 |
Why?
|
Prospective Studies | 5 | 2018 | 54807 | 0.030 |
Why?
|
Prednisone | 2 | 2014 | 1566 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9525 | 0.030 |
Why?
|
Receptor, erbB-2 | 2 | 2004 | 2592 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2020 | 445 | 0.030 |
Why?
|
Age Factors | 4 | 2017 | 18382 | 0.030 |
Why?
|
Dental Implantation, Endosseous | 1 | 2020 | 520 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2021 | 1739 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2848 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 1979 | 643 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2021 | 12973 | 0.030 |
Why?
|
Bone Transplantation | 1 | 2020 | 920 | 0.030 |
Why?
|
Marital Status | 1 | 2017 | 426 | 0.030 |
Why?
|
Mandible | 1 | 2020 | 746 | 0.030 |
Why?
|
Databases, Factual | 3 | 2017 | 8060 | 0.030 |
Why?
|
Body Mass Index | 1 | 2013 | 13042 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2002 | 6306 | 0.030 |
Why?
|
Granulocytes | 1 | 1997 | 548 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2020 | 903 | 0.030 |
Why?
|
Doxorubicin | 2 | 2014 | 2226 | 0.030 |
Why?
|
Retrospective Studies | 7 | 2019 | 81537 | 0.030 |
Why?
|
Drug Interactions | 1 | 2019 | 1416 | 0.030 |
Why?
|
Cold Temperature | 1 | 1978 | 793 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2000 | 1189 | 0.030 |
Why?
|
Safety | 1 | 2019 | 1157 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1997 | 633 | 0.030 |
Why?
|
Time Factors | 6 | 2016 | 40097 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10727 | 0.030 |
Why?
|
Ovarian Neoplasms | 2 | 2015 | 4904 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1787 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15645 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11030 | 0.030 |
Why?
|
Granulocyte Precursor Cells | 1 | 2012 | 49 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13273 | 0.030 |
Why?
|
Brain | 1 | 2019 | 27179 | 0.030 |
Why?
|
Daunorubicin | 1 | 2012 | 157 | 0.030 |
Why?
|
Carcinoma | 1 | 2004 | 2311 | 0.030 |
Why?
|
Breast | 1 | 2021 | 1950 | 0.030 |
Why?
|
Karyotyping | 1 | 2014 | 1175 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2014 | 451 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14745 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 641 | 0.020 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2012 | 317 | 0.020 |
Why?
|
Perception | 1 | 2018 | 1204 | 0.020 |
Why?
|
Signal Transduction | 1 | 2015 | 23597 | 0.020 |
Why?
|
Hot Temperature | 1 | 1978 | 1433 | 0.020 |
Why?
|
Medically Uninsured | 1 | 2017 | 838 | 0.020 |
Why?
|
Peripheral Nervous System | 1 | 2012 | 151 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1984 | 2325 | 0.020 |
Why?
|
Biopsy | 2 | 2021 | 6766 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3490 | 0.020 |
Why?
|
Neoplasms | 2 | 2015 | 22340 | 0.020 |
Why?
|
Recombinant Proteins | 3 | 2000 | 6491 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 24275 | 0.020 |
Why?
|
Azacitidine | 1 | 2012 | 334 | 0.020 |
Why?
|
Inverted Repeat Sequences | 1 | 2010 | 59 | 0.020 |
Why?
|
Thrombocytopenia | 3 | 2000 | 1172 | 0.020 |
Why?
|
Risk Factors | 4 | 2019 | 74850 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21513 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15540 | 0.020 |
Why?
|
Liver | 1 | 2006 | 7559 | 0.020 |
Why?
|
Anorexia Nervosa | 1 | 1979 | 1328 | 0.020 |
Why?
|
Bone and Bones | 1 | 2020 | 2555 | 0.020 |
Why?
|
Ear, Middle | 1 | 1992 | 341 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2004 | 9239 | 0.020 |
Why?
|
Pain | 2 | 2021 | 5077 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 474 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2530 | 0.020 |
Why?
|
Wound Healing | 1 | 2020 | 2794 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2510 | 0.020 |
Why?
|
Autoantibodies | 1 | 1978 | 2114 | 0.020 |
Why?
|
Aspirin | 1 | 1981 | 3135 | 0.020 |
Why?
|
Radiography | 3 | 2007 | 6941 | 0.020 |
Why?
|
Leukocytes | 2 | 1974 | 2027 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 2031 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3661 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 657 | 0.020 |
Why?
|
Erythrocytes | 1 | 1978 | 2394 | 0.020 |
Why?
|
Lung | 1 | 2007 | 10046 | 0.020 |
Why?
|
Leucovorin | 2 | 2001 | 643 | 0.020 |
Why?
|
Palliative Care | 3 | 2016 | 3640 | 0.020 |
Why?
|
Decision Making | 2 | 2018 | 3955 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1751 | 0.020 |
Why?
|
Income | 1 | 2017 | 1874 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2012 | 1440 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 1984 | 4349 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 2007 | 0.020 |
Why?
|
Fatal Outcome | 2 | 2005 | 1835 | 0.020 |
Why?
|
Thalidomide | 1 | 2013 | 886 | 0.020 |
Why?
|
Neutrophils | 1 | 1980 | 3769 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2017 | 2046 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20690 | 0.020 |
Why?
|
Lung Neoplasms | 3 | 2007 | 13446 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3608 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2016 | 4859 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2653 | 0.020 |
Why?
|
Fibrinogen | 1 | 2010 | 895 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4037 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 1983 | 4278 | 0.020 |
Why?
|
Antibodies | 1 | 1974 | 2415 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9334 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2125 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 1983 | 6360 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4746 | 0.020 |
Why?
|
Platelet Count | 2 | 2000 | 784 | 0.020 |
Why?
|
Factor V | 1 | 2006 | 168 | 0.020 |
Why?
|
Melanoma | 1 | 1984 | 5695 | 0.020 |
Why?
|
Poverty | 1 | 2017 | 2714 | 0.020 |
Why?
|
Cohort Studies | 1 | 2008 | 41680 | 0.020 |
Why?
|
Spine | 1 | 1992 | 1132 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6209 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2009 | 1865 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2006 | 527 | 0.010 |
Why?
|
Farnesyltranstransferase | 1 | 2004 | 70 | 0.010 |
Why?
|
Ascites | 1 | 2006 | 336 | 0.010 |
Why?
|
Duodenum | 1 | 2007 | 496 | 0.010 |
Why?
|
Salmonella | 2 | 1974 | 122 | 0.010 |
Why?
|
Anxiety | 1 | 2019 | 4669 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9656 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 26380 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2833 | 0.010 |
Why?
|
Carbon Radioisotopes | 2 | 1974 | 543 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4424 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 2006 | 463 | 0.010 |
Why?
|
Janus Kinase 2 | 1 | 2006 | 562 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3606 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12529 | 0.010 |
Why?
|
Salivary Glands | 1 | 2004 | 231 | 0.010 |
Why?
|
Neoplasm Metastasis | 2 | 2003 | 4882 | 0.010 |
Why?
|
Models, Chemical | 1 | 2004 | 607 | 0.010 |
Why?
|
Infant | 1 | 2004 | 36426 | 0.010 |
Why?
|
Christianity | 1 | 2002 | 52 | 0.010 |
Why?
|
Splenomegaly | 1 | 1982 | 191 | 0.010 |
Why?
|
Tegafur | 1 | 2001 | 38 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2007 | 810 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2007 | 2232 | 0.010 |
Why?
|
Mitochondria | 1 | 2015 | 3669 | 0.010 |
Why?
|
Bleeding Time | 1 | 1981 | 83 | 0.010 |
Why?
|
Child, Preschool | 1 | 2004 | 42510 | 0.010 |
Why?
|
Phenylmethylsulfonyl Fluoride | 1 | 1980 | 6 | 0.010 |
Why?
|
Ethylmaleimide | 1 | 1980 | 69 | 0.010 |
Why?
|
Phenanthrolines | 1 | 1980 | 48 | 0.010 |
Why?
|
Heart | 1 | 2014 | 4419 | 0.010 |
Why?
|
Lymphatic Diseases | 1 | 1982 | 316 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1980 | 165 | 0.010 |
Why?
|
Carbon Dioxide | 2 | 1974 | 1138 | 0.010 |
Why?
|
Edetic Acid | 1 | 1980 | 274 | 0.010 |
Why?
|
Uracil | 1 | 2001 | 210 | 0.010 |
Why?
|
Fever | 1 | 2007 | 1607 | 0.010 |
Why?
|
Ultrasonography | 2 | 2006 | 5987 | 0.010 |
Why?
|
Area Under Curve | 1 | 2003 | 1637 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8223 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1986 | 1374 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 1980 | 238 | 0.010 |
Why?
|
Antigens, CD | 1 | 2009 | 4023 | 0.010 |
Why?
|
Antigens, Bacterial | 2 | 1974 | 1146 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2227 | 0.010 |
Why?
|
Pleural Neoplasms | 1 | 1983 | 583 | 0.010 |
Why?
|
Hodgkin Disease | 1 | 1986 | 1383 | 0.010 |
Why?
|
Phagocytosis | 2 | 1974 | 1517 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2027 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9599 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4563 | 0.010 |
Why?
|
Pilot Projects | 2 | 1997 | 8724 | 0.010 |
Why?
|
United States | 2 | 2017 | 72909 | 0.010 |
Why?
|
Religion | 1 | 2002 | 375 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8346 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1980 | 1724 | 0.010 |
Why?
|
Cerebellar Diseases | 1 | 2000 | 227 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 1983 | 1130 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2000 | 1376 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4617 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13463 | 0.010 |
Why?
|
Drug Eruptions | 1 | 2000 | 334 | 0.010 |
Why?
|
Filgrastim | 1 | 1997 | 132 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 1999 | 432 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2006 | 2423 | 0.010 |
Why?
|
Kidney | 1 | 1992 | 7073 | 0.010 |
Why?
|
Random Allocation | 1 | 1981 | 2394 | 0.010 |
Why?
|
Ethics, Medical | 1 | 2002 | 785 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1984 | 2885 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5379 | 0.010 |
Why?
|
Child | 1 | 2004 | 80568 | 0.010 |
Why?
|
Actins | 1 | 1983 | 2057 | 0.010 |
Why?
|
Exanthema | 1 | 2000 | 503 | 0.010 |
Why?
|
Hip Prosthesis | 1 | 1981 | 895 | 0.010 |
Why?
|
Neutropenia | 1 | 2000 | 894 | 0.010 |
Why?
|
Disease Progression | 2 | 2003 | 13614 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5889 | 0.010 |
Why?
|
Latex Fixation Tests | 1 | 1974 | 29 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1982 | 21069 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1974 | 212 | 0.010 |
Why?
|
Fatigue | 1 | 2001 | 1553 | 0.010 |
Why?
|
Methods | 1 | 1974 | 1061 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2006 | 4520 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2013 | 6544 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1997 | 1605 | 0.010 |
Why?
|
Serologic Tests | 1 | 1974 | 382 | 0.010 |
Why?
|
Glucose | 2 | 1974 | 4335 | 0.010 |
Why?
|
Hypertension | 1 | 1992 | 8616 | 0.010 |
Why?
|
Automation | 1 | 1974 | 585 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2000 | 1568 | 0.010 |
Why?
|
Syndrome | 1 | 1978 | 3271 | 0.010 |
Why?
|
Anemia | 1 | 2001 | 1514 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2003 | 3592 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2007 | 6542 | 0.010 |
Why?
|
Algorithms | 1 | 2011 | 14064 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14643 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1983 | 4909 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 1986 | 8037 | 0.010 |
Why?
|
Cause of Death | 1 | 2000 | 3715 | 0.010 |
Why?
|
Dogs | 1 | 1974 | 3824 | 0.000 |
Why?
|
Mice | 1 | 2014 | 81782 | 0.000 |
Why?
|
Animals | 3 | 2014 | 168735 | 0.000 |
Why?
|
Double-Blind Method | 1 | 2000 | 12417 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 1984 | 5836 | 0.000 |
Why?
|
Models, Structural | 1 | 1983 | 338 | 0.000 |
Why?
|
Microcomputers | 1 | 1983 | 139 | 0.000 |
Why?
|
Gelsolin | 1 | 1983 | 189 | 0.000 |
Why?
|
Hematologic Diseases | 1 | 1986 | 500 | 0.000 |
Why?
|
Lipids | 1 | 1992 | 3317 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1983 | 2543 | 0.000 |
Why?
|
Muscles | 1 | 1983 | 1577 | 0.000 |
Why?
|
Cytoskeleton | 1 | 1983 | 1178 | 0.000 |
Why?
|
Rabbits | 1 | 1983 | 4729 | 0.000 |
Why?
|